A5073251236- Inhalation and Respiratory Drug Delivery
- Advanced Drug Delivery Systems
- Nanoparticle-Based Drug Delivery
- Advancements in Transdermal Drug Delivery
- COVID-19 Clinical Research Studies
- Curcumin's Biomedical Applications
- Natural Antidiabetic Agents Studies
- Pediatric health and respiratory diseases
- RNA Interference and Gene Delivery
- Asthma and respiratory diseases
- Pharmacological Effects of Natural Compounds
- Medicinal Plants and Neuroprotection
- SARS-CoV-2 and COVID-19 Research
- Antimicrobial Peptides and Activities
- Gut microbiota and health
- MicroRNA in disease regulation
- Berberine and alkaloids research
- Essential Oils and Antimicrobial Activity
- Drug Solubulity and Delivery Systems
- Phytochemicals and Antioxidant Activities
- Advanced biosensing and bioanalysis techniques
- Herbal Medicine Research Studies
- Nanoplatforms for cancer theranostics
- Alzheimer's disease research and treatments
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
International Medical University
2016-2025
Institute for Medical Research
2025
University of Technology Sydney
2021
University Kebangsaan Malaysia Medical Centre
2021
Michigan United
2020
Vinayaka Missions University
2014
Manipal Academy of Higher Education
2004-2012
University of Bahrain
2010
Boston Children's Hospital
2009
In this study, we had developed Naringenin-loaded liquid crystalline nanoparticles (LCNs) and investigated the anti-inflammatory anticancer activities of Naringenin-LCNs against human airway epithelium-derived basal cells (BCi-NS1.1) lung epithelial carcinoma (A549) cell lines, respectively. The potential evaluated by qPCR revealed a decreased expression IL-6, IL-8, IL-1β, TNF-α in lipopolysaccharide-induced BCi-NS1.1 cells. activity LCNs was comparable to positive control drug Fluticasone...